The Defense Health Agency awarded Dana-Farber Cancer Institute a $712,001 Project Grant under the Military Medical Research and Development program to conduct research on understanding the role of DNA damage repair deficiency in Ewing sarcoma pathogenesis through integrative computational biology. The three-year award runs from September 1, 2023 through August 31, 2026.
Through this funding, Dana-Farber will utilize computational methods to analyze Ewing sarcoma tumor samples and related clinical data to better understand the relationship between DNA repair deficiencies and disease progression. Insights gained from this research could help identify novel therapeutic targets and improve treatment outcomes for patients with this rare and difficult to treat form of bone cancer that typically affects children and young adults. The Military Medical Research and Development program supports innovative medical research with the goals of transforming military and public health care through new solutions applicable both on the battlefield and in civilian medicine.
Generated 3/5/24, 8:51 AM